Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy.

Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy.
Am J Trop Med Hyg. 2020 Sep 16;:
Authors: Otsuka Y, Kobayashi T
Abstract
COVID-19 has now spread globally, and 10-20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prolonged fever, the patient's respiratory condition deteriorated rapidly, and he died. COVID-19 in immunocompromised patients after chemotherapy, even with mild symptoms, can cause rapid immune reconstitution and respiratory deterioration. Therefore, caution is advised until negative PCR test results for SARS-CoV-2 are confirmed.
PMID: 32940203 [PubMed - as supplied by publisher]

Source: The American Journal of Tropical Medicine and Hygiene - September 15, 2020 Category: Tropical Medicine Authors: Otsuka Y, Kobayashi T Tags: Am J Trop Med Hyg Source Type: research